ULGX Financial Facts
Gross profit: 1.31MResearch and development: 298K
See Full Income Statement
Prepaid and other current assets: 160K
Long-term deferred acquisition payments: 3.41M
See Full Balance Sheet
Urologix, Inc. (ULGX) Earnings
|
Expand Research on ULGX
Next EPS Date | 5/15/24 | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +4.2% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/15/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
2/9/24 | Q423 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
2/12/24 | Q423 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
2/26/24 | Q423 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
2/19/24 | Q423 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/1/23 | Q323 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/6/23 | Q323 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/13/23 | Q323 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |